This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Creabilis Therapeutics S.p.a., Bionucleon S.r.l.. Active years: 2009-2014.
Company Filing History:
Years Active: 2009-2014
Title: Innovations and Contributions of Inventor Domenico Barone
Introduction
Domenico Barone is a notable inventor based in Turin, Italy. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compositions. With a total of 4 patents, his work focuses on innovative solutions for various medical conditions.
Latest Patents
One of his latest patents is titled "Inhibition of HRP-3 using modified oligonucleotides." This invention refers to agents that modulate the activity of proteins possessing a PWWP domain. Another significant patent is "Polymer conjugates of K-252A and derivatives thereof." This invention relates to novel polymer conjugates of K-252a and their derivatives, which are useful in preparing pharmaceutical compositions for preventing and treating kinase-associated pathologies. Specifically, it addresses neurological disorders, dermal pathologies such as psoriasis, and NGF-related pain.
Career Highlights
Domenico Barone has worked with several companies, including Creabilis Therapeutics S.p.a. and Bionucleon S.r.l. His experience in these organizations has contributed to his expertise in the field of biotechnology and pharmaceuticals.
Collaborations
Throughout his career, Barone has collaborated with notable colleagues, including Luisa Bertarione Rava Rossa and Silvano Fumero. These collaborations have further enhanced his research and development efforts.
Conclusion
Domenico Barone's innovative work and patents reflect his commitment to advancing medical science. His contributions are significant in addressing various health challenges through biotechnology.